Financial Freedom LLC’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$332K Buy
2,759
+6
+0.2% +$693 0.17% 82
2025
Q4
$290K Buy
2,753
+6
+0.2% +$563 0.14% 86
2025
Q3
$231K Buy
2,747
+14
+0.5% +$1.15K 0.11% 98
2025
Q2
$216K Buy
2,733
+12
+0.4% +$954 0.12% 101
2025
Q1
$244K Buy
2,721
+10
+0.4% +$934 0.14% 89
2024
Q4
$270K Buy
2,711
+9
+0.3% +$928 0.14% 80
2024
Q3
$307K Buy
2,702
+8
+0.3% +$950 0.16% 78
2024
Q2
$334K Buy
2,694
+8
+0.3% +$1.03K 0.19% 74
2024
Q1
$354K Buy
2,686
+8
+0.3% +$986 0.21% 76
2023
Q4
$292K Sell
2,678
-95
-3% -$9.86K 0.19% 75
2023
Q3
$286K Buy
2,773
+8
+0.3% +$862 0.2% 73
2023
Q2
$319K Buy
2,765
+8
+0.3% +$908 0.22% 64
2023
Q1
$293K Buy
2,757
+8
+0.3% +$864 0.21% 65
2022
Q4
$305K Buy
+2,749
New +$281K 0.21% 61

Other funds holding MRK

Financial Freedom LLC's MRK Position: Q1 2026 in Review

Financial Freedom LLC increased its Merck (MRK) stake by 0.22% in Q1 2026, buying an estimated $693 and bringing the position to 2,759 shares worth $332K. The position accounts for 0.17% of the portfolio, ranked #82.

Financial Freedom LLC first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $354K in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Financial Freedom LLC held 2,759 shares of Merck worth $332K as of Q1 2026.
  • Financial Freedom LLC bought 6 Merck shares in Q1 2026, an estimated $693.
  • Merck made up 0.17% of Financial Freedom LLC's portfolio in Q1 2026, its #82 holding.
  • Financial Freedom LLC first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • Financial Freedom LLC's Merck position peaked at $354K in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Financial Freedom LLC's 13F filing for Q1 2026, filed 30 Apr 2026.